Patients | Total | CD171 positive* | CD171 negative |
---|---|---|---|
N (%) | 30 (100) | 15 (50) | 15 (50) |
Minimum age at diagnosis (years) | 0.1 | 0.4 | 0.1 |
Maximum age at diagnosis (years) | 6.5 | 6.4 | 6.5 |
Median age at diagnosis (years) | 2.1 (0.12–6.5) | 1.8 | 2.1 |
Sex (%) | ♀: 15 (50) | ♀:9 (60) | ♀:6 (40) |
♂: 15 (50) | ♂:6 (40) | ♂:9 (60) | |
Unilateral (%) | 23 (77) | 12 (80) | 11 (73) |
Bilateral (%) | 7 (23) | 3 (20) | 4 (27) |
ICRB (%) | |||
 A | 0 (0) | 0 (0) | 0 (0) |
 B | 0 (0) | 0 (0) | 0 (0) |
 C | 1 (3) | 1 (7) | 0 (0) |
 D | 17 (57) | 9 (60) | 7 (47) |
 E | 7 (20) | 3 (20) | 4 (26) |
 n.a. | 6 (20) | 2 (13) | 4 (26) |